Homeostatic membrane tension constrains cancer cell dissemination by counteracting BAR protein assembly.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 10 2021
Historique:
received: 02 03 2020
accepted: 16 09 2021
entrez: 12 10 2021
pubmed: 13 10 2021
medline: 4 11 2021
Statut: epublish

Résumé

Malignancy is associated with changes in cell mechanics that contribute to extensive cell deformation required for metastatic dissemination. We hypothesized that the cell-intrinsic physical factors that maintain epithelial cell mechanics could function as tumor suppressors. Here we show, using optical tweezers, genetic interference, mechanical perturbations, and in vivo studies, that epithelial cells maintain higher plasma membrane (PM) tension than their metastatic counterparts and that high PM tension potently inhibits cancer cell migration and invasion by counteracting membrane curvature sensing/generating BAR family proteins. This tensional homeostasis is achieved by membrane-to-cortex attachment (MCA) regulated by ERM proteins, whose disruption spontaneously transforms epithelial cells into a mesenchymal migratory phenotype powered by BAR proteins. Consistently, the forced expression of epithelial-mesenchymal transition (EMT)-inducing transcription factors results in decreased PM tension. In metastatic cells, increasing PM tension by manipulating MCA is sufficient to suppress both mesenchymal and amoeboid 3D migration, tumor invasion, and metastasis by compromising membrane-mediated mechanosignaling by BAR proteins, thereby uncovering a previously undescribed mechanical tumor suppressor mechanism.

Identifiants

pubmed: 34635648
doi: 10.1038/s41467-021-26156-4
pii: 10.1038/s41467-021-26156-4
pmc: PMC8505629
doi:

Substances chimiques

DNA-Binding Proteins 0
ETV5 protein, human 0
Transcription Factors 0
RHOA protein, human 124671-05-2
SLK protein, human EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1
rhoA GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5930

Informations de copyright

© 2021. The Author(s).

Références

Genes Dev. 2016 Jul 1;30(13):1542-57
pubmed: 27401557
Acta Biomater. 2007 Jul;3(4):413-38
pubmed: 17540628
Nat Rev Mol Cell Biol. 2001 May;2(5):392-6
pubmed: 11331914
Cell Stem Cell. 2021 Feb 4;28(2):273-284.e6
pubmed: 33217323
Nat Rev Cancer. 2011 Jun 24;11(7):512-22
pubmed: 21701513
Dev Cell. 2020 Sep 14;54(5):608-623.e5
pubmed: 32877650
PLoS Biol. 2010 Nov 30;8(11):e1000544
pubmed: 21151339
Nat Commun. 2019 Sep 13;10(1):4185
pubmed: 31519914
Mol Oncol. 2007 Jun;1(1):84-96
pubmed: 18516279
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Nat Rev Cancer. 2011 Oct 13;11(11):761-74
pubmed: 21993244
Dev Cell. 2005 Dec;9(6):791-804
pubmed: 16326391
Cell. 2017 Feb 9;168(4):670-691
pubmed: 28187288
Trends Cell Biol. 2012 Oct;22(10):527-35
pubmed: 22921414
Trends Cancer. 2017 Jun;3(6):391-406
pubmed: 28670628
Nature. 2005 May 19;435(7040):365-9
pubmed: 15902261
Curr Biol. 2013 Aug 5;23(15):1409-17
pubmed: 23831292
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7630-5
pubmed: 22547795
Nat Commun. 2014 Nov 21;5:5458
pubmed: 25413277
Sci Rep. 2013;3:1449
pubmed: 23618955
Cancer Res. 2011 Aug 1;71(15):5075-80
pubmed: 21642375
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6532-7
pubmed: 10823888
Gut. 2018 Aug;67(8):1400-1409
pubmed: 28647685
Nat Cell Biol. 2018 Sep;20(9):1023-1031
pubmed: 30061681
Dev Cell. 2021 Jan 25;56(2):164-179
pubmed: 33238151
J Cell Sci. 2008 May 1;121(Pt 9):1444-54
pubmed: 18413296
Cell. 2000 Jan 21;100(2):221-8
pubmed: 10660045
Dev Cell. 2017 Dec 4;43(5):577-587.e5
pubmed: 29173819
Cell Stem Cell. 2021 Feb 4;28(2):209-216.e4
pubmed: 33207217
Nat Cell Biol. 2015 Jun;17(6):749-58
pubmed: 25938814
BMC Biotechnol. 2011 Dec 16;11:124
pubmed: 22176647
Nat Cell Biol. 2020 Jan;22(1):120-134
pubmed: 31871319
Breast Cancer Res Treat. 2006 Jul;98(1):71-9
pubmed: 16538541
Lab Invest. 2000 Nov;80(11):1643-50
pubmed: 11092524
Nat Rev Mol Cell Biol. 2017 Dec;18(12):743-757
pubmed: 29115298
Cell. 2011 Nov 23;147(5):992-1009
pubmed: 22118458
Mol Biol Cell. 2011 Feb 1;22(3):327-41
pubmed: 21148292
Curr Biol. 2008 Jan 22;18(2):91-101
pubmed: 18207738
Nat Commun. 2015 Jan 08;6:5974
pubmed: 25569184
Sci Rep. 2019 Nov 8;9(1):16351
pubmed: 31705019
Dev Cell. 2020 Dec 21;55(6):723-736.e8
pubmed: 33308479
Nat Cell Biol. 2017 May;19(5):530-541
pubmed: 28414314
Semin Cell Dev Biol. 2017 Nov;71:30-41
pubmed: 28851599
Nat Rev Mol Cell Biol. 2013 Jul;14(7):405-15
pubmed: 23778968
Nat Commun. 2015 May 26;6:7219
pubmed: 26008710
Physiol Rev. 2014 Oct;94(4):1219-48
pubmed: 25287863
Breast Cancer Res Treat. 2012 Aug;134(3):981-8
pubmed: 22415480
Sci Rep. 2015 Oct 05;5:14700
pubmed: 26435322
Breast Cancer Res Treat. 2010 Oct;123(3):725-31
pubmed: 20020197
Science. 2020 Jun 12;368(6496):1205-1210
pubmed: 32527825
Cell. 2018 Dec 13;175(7):1769-1779.e13
pubmed: 30392960
Nat Phys. 2018 Jul;14(7):648-652
pubmed: 31007706
Nat Rev Cancer. 2017 Feb;17(2):131-140
pubmed: 27909339
J Cell Biol. 2000 Jan 10;148(1):127-36
pubmed: 10629223
J Cell Biol. 2003 Jan 20;160(2):267-77
pubmed: 12527751
Soft Matter. 2012;8(32):8350-8360
pubmed: 23227105
Dev Cell. 2014 Sep 8;30(5):553-68
pubmed: 25203208
J Cell Biol. 2014 Mar 3;204(5):839-56
pubmed: 24590176
Cell Rep. 2017 May 23;19(8):1495-1502
pubmed: 28538170
J Cell Sci. 2011 Apr 15;124(Pt 8):1256-67
pubmed: 21444753
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
EMBO J. 2021 Jan 15;40(2):e106123
pubmed: 33274785
Nat Rev Mol Cell Biol. 2010 Apr;11(4):276-87
pubmed: 20308985
Nat Nanotechnol. 2007 Dec;2(12):780-3
pubmed: 18654431
Nat Phys. 2020 Jan;16(1):101-108
pubmed: 32905405
Biol Cell. 2017 May;109(5):167-189
pubmed: 28244605
Cell. 2012 Jan 20;148(1-2):175-88
pubmed: 22265410
Oncogene. 2013 Jun 20;32(25):3080-90
pubmed: 22824798
Head Neck Pathol. 2012 Jun;6(2):232-43
pubmed: 22228071
PLoS Biol. 2016 Jun 09;14(6):e1002474
pubmed: 27280401
Cancer Res. 1961 Jan;21:38-9
pubmed: 13788099
Nat Nanotechnol. 2012 Nov;7(11):757-65
pubmed: 23085644
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18707-12
pubmed: 23112172
Nat Cell Biol. 2003 Aug;5(8):711-9
pubmed: 12844144
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Cell. 2015 Feb 12;160(4):659-672
pubmed: 25679760
Nature. 2003 Jan 2;421(6918):83-7
pubmed: 12511959
J Phys Condens Matter. 2015 Jul 15;27(27):273103
pubmed: 26061624
Oncogene. 2016 Jan 28;35(4):501-12
pubmed: 25867068
Am J Physiol Cell Physiol. 2015 Mar 15;308(6):C436-47
pubmed: 25500742
Cell. 2008 Oct 31;135(3):510-23
pubmed: 18984162
J Cell Biol. 2012 Dec 10;199(6):969-84
pubmed: 23209304
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14434-9
pubmed: 22786929
Cell. 2006 Nov 17;127(4):679-95
pubmed: 17110329

Auteurs

Kazuya Tsujita (K)

Biosignal Research Center, Kobe University, Kobe, Hyogo, 657-8501, Japan. tsujita@people.kobe-u.ac.jp.
Division of Membrane Biology, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Hyogo, 650-0017, Japan. tsujita@people.kobe-u.ac.jp.
AMED-PRIME, Japan Agency for Medical Research and Development, Tokyo, 100-0004, Japan. tsujita@people.kobe-u.ac.jp.

Reiko Satow (R)

Laboratory of Genome and Biosignals, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.

Shinobu Asada (S)

Laboratory of Genome and Biosignals, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.

Yoshikazu Nakamura (Y)

Laboratory of Genome and Biosignals, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.
Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, 278-8510, Japan.

Luis Arnes (L)

The Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), Biotech Research & Innovation Centre, University of Copenhagen, Copenhagen, Denmark.

Keisuke Sako (K)

National Cerebral and Cardiovascular Center Research Institute, Osaka, 565-8565, Japan.

Yasuyuki Fujita (Y)

Division of Molecular Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.

Kiyoko Fukami (K)

Laboratory of Genome and Biosignals, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.

Toshiki Itoh (T)

Biosignal Research Center, Kobe University, Kobe, Hyogo, 657-8501, Japan.
Division of Membrane Biology, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Hyogo, 650-0017, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH